Author:
Bhat Abdul,Turnbull Amy,Aijaz Abir,Badshah Amit
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. National Institute for Health and Care Excellence. Patiromer for treating hyperkalaemia (TA623). (2020). https.//www.clinicalkey.com/#!/content/nice_guidelines/65-s2.0-TA623.
2. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology;Rosano GM;Eur Heart J Cardiovasc Pharmacother,2018
3. Chapter 15: evaluation of renal function, water, electrolytes and acid-base balance;Oh M,2021
4. Electrophysiology of hypokalemia and hyperkalemia;Weiss JN;Circ Arrhythm Electrophysiol,2017
5. Neurological complications of systemic disease: adults;Josephson S,2022